2019 American Transplant Congress
Economic Impact of Donor Hepatitis C Kidney Transplantation: A Medicare Cost Analysis
*Purpose: In the era of highly effective direct-acting antiviral agents (DAAs), kidney transplant (KT) from Hepatitis C virus (HCV)-positive donors is increasingly considered as an…2019 American Transplant Congress
The Impact of Transplant Hospital Organ Procurement on Medicare Cost Report Reimbursement
*Purpose: Medicare organ acquisition reimbursement from the Medicare Cost Report includes costs associated with transplant hospitals acquiring an organ for Medicare transplant patients and the…2019 American Transplant Congress
Donor-derived Cell-free Dna In Donor Specific Antibody Positive Kidney Transplant Recipients
*Purpose: Donor-derived cell-free DNA (dd-cfDNA) is an emerging biomarker of kidney allograft injury. Studies examining the clinical validity of this biomarker have identified cut off…2019 American Transplant Congress
Insurance Status Impacts Treatment for Hepatocellular Carcinoma
*Purpose: Previous studies have identified treatment disparities in the treatment of hepatocellular carcinoma (HCC) based on insurance status and provider. Recent studies have shown more…2018 American Transplant Congress
Taking Your Center's Temperature: Using a Heat Map to Target Your Transplant-Specific Education for Regulatory Compliance
Medical University of South Carolina, Charleston.
Background: Large, multi-organ transplant centers struggle with implementation of a comprehensive strategy for development and execution of a Transplant-specific education plan. Regulatory requirements for staff…2018 American Transplant Congress
Cost Effectiveness of Lifelong Medicare Immunosuppressant Drug Coverage for Kidney Transplant Recipients in the Current Era
While there is no Medicare time limit for dialysis patients, kidney transplant recipients lose their Medicare coverage 36 months after they receive their transplant. The…2018 American Transplant Congress
Medicare Part D Plans Deny Coverage for Off-Label and Off-Compendia Immunosuppressant Use: A Case Series
Immunosuppressants are a protected drug class under the Medicare Part D benefit, meaning that all drugs in this class must be present on all plan…2017 American Transplant Congress
Transplant Economics Post Implementation of the Affordable Care Act and the Budget Control Act Sequestration Adjustment on Medicare Reimbursement.
1VUMC, Nashville; 2Tx Mgmt Group, San Diego; 3Mayo Clinic, Jacksonville
Purpose: Adjustments in the Affordable Care Act (ACA) of 2010 and sequestration from the Budget Control Act (BCA) of 2011 have impacted Medicare reimbursement for…2017 American Transplant Congress
A Kidney Paired Donation Standard Acquisition Charge.
Introduction: A non-profit kidney paired donation (KPD) organization undertook an Agency for Healthcare Research and Quality (AHRQ)-funded demonstration project to redesign reimbursement for the costs…2017 American Transplant Congress
Twenty Year Trends in Outcomes and Costs Following Kidney Transplantation.
Purpose. Short term outcomes of kidney transplantation (KTx) are excellent, but it is unclear that long term outcomes have improved, despite advances in immunosuppression (IS).…
American Transplant Congress abstracts